Veterinary Medicines

Vigophos 100 mg / ml + 0.05 mg / ml solution for injection for cattle, horses and dogs

Authorised
  • Cyanocobalamin
  • Butafosfan
Download as PDF

Product identification

Medicine name:
Vigophos 100 mg / ml + 0.05 mg / ml solution for injection for cattle
Vigophos 100 mg / ml + 0.05 mg / ml solution for injection for cattle, horses and dogs
Active substance:
  • Cyanocobalamin
  • Butafosfan
Target species:
  • Cattle
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Cyanocobalamin
    0.05
    milligram(s)
    /
    1.00
    millilitre(s)
  • Butafosfan
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Carton containing 12 Type II amber glass vials of 100 ml closed with a coated bromobutyl or chlorobutyl rubber stopper and sealed with an aluminium cap
  • Carton containing 6 Type II amber glass vial of 100 ml closed with a coated bromobutyl or chlorobutyl rubber stopper and sealed with an aluminium cap
  • Carton containing 1 Type II amber glass vial of 100 ml closed with a coated bromobutyl or chlorobutyl rubber stopper and sealed with an aluminium cap

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Industrial Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • Industrial Veterinaria S.A.
  • aniMedica Herstellungs GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10425/007/001
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0426/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 15/02/2022
Download

Combined File of all Documents

English (PDF)
Published on: 22/02/2024
Download

PuAR updated.pdf

English (PDF)
Published on: 26/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."